M. Balasubramanian

The Group's principal activity is to manufacture and export pharmaceuticals formulation for human health and animal health. It exports its product to Europe, South America, Australia, Asia and Africa.

The Group's principal activity is to manufacture and export pharmaceuticals formulation for human health and animal health. It exports its product to Europe, South America, Australia, Asia and Africa.

The Group's principal activity is to manufacture and export pharmaceuticals formulation for human health and animal health. It exports its product to Europe, South America, Australia, Asia and Africa.

The Group's principal activity is to manufacture and export pharmaceuticals formulation for human health and animal health. It exports its product to Europe, South America, Australia, Asia and Africa.

The Group's principal activity is to manufacture and export pharmaceuticals formulation for human health and animal health. It exports its product to Europe, South America, Australia, Asia and Africa.

The Group's principal activity is to manufacture and export pharmaceuticals formulation for human health and animal health. It exports its product to Europe, South America, Australia, Asia and Africa.

The Group's principal activity is to manufacture and export pharmaceuticals formulation for human health and animal health. It exports its product to Europe, South America, Australia, Asia and Africa.

The Group's principal activity is to manufacture and export pharmaceuticals formulation for human health and animal health. It exports its product to Europe, South America, Australia, Asia and Africa.